News Focus
News Focus
Followers 46
Posts 2717
Boards Moderated 0
Alias Born 12/19/2015

Re: sukus post# 535458

Saturday, 11/19/2022 9:03:49 AM

Saturday, November 19, 2022 9:03:49 AM

Post# of 822258
Makes sense. With a benign side effect profile this therapy will be in HIGH demand. Will the company be able to meet demand? That will be the primary question. A BP partner could be the answer to that question…
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News